Iptacopan is a selective factor B inhibitor belonging to the complement inhibitor class, indicated for the treatment of paroxysmal nocturnal hemoglobinuria. The related compounds, impurities, metabolites,… Read more





















Iptacopan is a selective factor B inhibitor belonging to the complement inhibitor class, indicated for the treatment of paroxysmal nocturnal hemoglobinuria. The related compounds, impurities, metabolites, and stable isotope-labelled standards found in this category are vital for rigorous pharmaceutical analysis. Laboratories utilize these high-quality reference standards to perform comprehensive impurity profiling, conduct method validation, and ensure the precise quality control of the active pharmaceutical ingredient. By providing access to specific degradation products, stereoisomers, and synthetic intermediates, this collection supports the critical assessment of compound stability and purity throughout the drug development lifecycle. These materials are essential for verifying analytical methods and meeting the regulatory requirements for consistency and safety in pharmaceutical manufacturing.